Psychotropic Drugs: Risks and Risk Management

Abstracts (HTML) List of Authors

Waldner-Knogler, K

Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)

Wenzel-Seifert, K

Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia

Wewetzer, C

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Wittmann, K

Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine

Wolf, M

Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM